Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

Benzinga Newsdesk www.benzinga.com Neutral 63.0%

Neg 0% Neu 63% Pos 0%

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Overweight rating and announces Price Target of $13.